Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842400 · ClinicalTrials.gov registry record · Phase 1
A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
A Phase 1 study, sponsored by VIVUS.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00842400 is a Phase 1 study that has completed, run by VIVUS. The registered enrollment target is 20 participants.
The verdict
NCT00842400, a Phase 1 study, has completed, sponsored by VIVUS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purposes of this study are to: * Find out how much of the study drugs are in the blood of healthy subjects after taking multiple doses of VI-0521, metformin and sitagliptan. * Determine the effect of probenecid on the amount of VI-0521 in the blood of healthy subjects after taking multiple doses. * Find out how much topiramate is in the semen of healthy male subjects after taking multiple doses.
Interventions
- DRUG Metformin, VI-0521, Sitagliptan, Probenecid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842400
The ClinicalTrials.gov registry entry for NCT00842400 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin, VI-0521, Sitagliptan, Probenecid is the first listed.
NCT00842400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842400 about?
NCT00842400 is a clinical study titled "A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.". The purposes of this study are to: * Find out how much of the study drugs are in the blood of healthy subjects after taking multiple doses of VI-0521, metformin and sitagliptan. * Determine the effect of probenecid on the amount of VI-0521 in the blood of healthy subjects after taking multiple dose...
What is the current status of trial NCT00842400?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00842400?
The interventions under investigation include: Metformin, VI-0521, Sitagliptan, Probenecid (DRUG).
Who is sponsoring clinical trial NCT00842400?
This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.